Vera Therapeutics, Inc. (NASDAQ: VERA) reported Q1 EPS of ($1.69), $0.36 worse than the analyst estimate of ($1.33).

For earnings history and earnings-related data on Vera Therapeutics, Inc. (VERA) click here.